• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用抗肿瘤坏死因子成功治疗的伴有严重踝关节强直并合并类风湿关节炎的坏疽性脓皮病:一例报告

Pyoderma Gangrenosum With Severe Ankle Ankylosis Complicated by Rheumatoid Arthritis Successfully Treated Using Anti-tumor Necrosis Factor: A Case Report.

作者信息

Nagase Takaaki, Takakubo Yuya, Wanezaki Yoshihiro, Aso Masashi, Takagi Michiaki

机构信息

Department of Orthopaedic Surgery, Yamagata University Faculty of Medicine, Yamagata, JPN.

Orthopaedics and Rehabilitation, Yamagata University Hospital, Yamagata, JPN.

出版信息

Cureus. 2024 Dec 12;16(12):e75614. doi: 10.7759/cureus.75614. eCollection 2024 Dec.

DOI:10.7759/cureus.75614
PMID:39803031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11724744/
Abstract

Pyoderma gangrenosum (PG) is a rare dermatosis characterised by necrotic ulcers with a predilection mainly for the lower legs. We report a case of a 67-year-old man with PG and severe ankle ankylosis complicated by rheumatoid arthritis (RA) treated with anti-tumor necrosis factor, adalimumab (ADA). He was referred to our hospital because his right ankle showed severe ulcers and blackening. X-rays of the right ankle and foot showed bone and joint destruction with ankylosis. Initially diagnosed with stasis dermatitis, he was treated, but his condition became increasingly worse. A skin biopsy revealed neutrophilic invasion of the skin tissue, and final diagnosis was PG complicated with RA and ankylosing joint. ADA therapy improved the patient's skin condition and reduced the right ankle pain, although severe right ankle ankylosis progressed during the last follow-up. PG should be considered as a differential in patients with RA and refractory skin ulcers.

摘要

坏疽性脓皮病(PG)是一种罕见的皮肤病,其特征为坏死性溃疡,主要好发于小腿。我们报告一例67岁男性患有PG并伴有严重的踝关节强直,该患者并发类风湿关节炎(RA),接受了抗肿瘤坏死因子药物阿达木单抗(ADA)治疗。他因右踝出现严重溃疡和发黑而被转诊至我院。右踝和足部的X线检查显示骨与关节破坏并伴有强直。最初诊断为淤积性皮炎,接受了治疗,但病情日益恶化。皮肤活检显示皮肤组织有中性粒细胞浸润,最终诊断为PG合并RA及关节强直。ADA治疗改善了患者的皮肤状况并减轻了右踝疼痛,尽管在最后一次随访时严重的右踝强直仍有进展。对于患有RA和难治性皮肤溃疡的患者,应考虑将PG作为鉴别诊断之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4581/11724744/2d4d66c2ff60/cureus-0016-00000075614-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4581/11724744/963fdd073124/cureus-0016-00000075614-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4581/11724744/286590a52ebb/cureus-0016-00000075614-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4581/11724744/2d4d66c2ff60/cureus-0016-00000075614-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4581/11724744/963fdd073124/cureus-0016-00000075614-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4581/11724744/286590a52ebb/cureus-0016-00000075614-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4581/11724744/2d4d66c2ff60/cureus-0016-00000075614-i03.jpg

相似文献

1
Pyoderma Gangrenosum With Severe Ankle Ankylosis Complicated by Rheumatoid Arthritis Successfully Treated Using Anti-tumor Necrosis Factor: A Case Report.使用抗肿瘤坏死因子成功治疗的伴有严重踝关节强直并合并类风湿关节炎的坏疽性脓皮病:一例报告
Cureus. 2024 Dec 12;16(12):e75614. doi: 10.7759/cureus.75614. eCollection 2024 Dec.
2
Successful switching treatment of adalimumab for refractory pyoderma gangrenosum in a patient with rheumatoid arthritis with prior use of tumour necrosis factor inhibitors: A case report and review of the literature.成功切换阿达木单抗治疗类风湿关节炎合并难治性坏疽性脓皮病患者:病例报告及文献复习。
Mod Rheumatol Case Rep. 2023 Jan 3;7(1):9-13. doi: 10.1093/mrcr/rxac023.
3
Neutrophilic Dermatosis of the Hands: A Case Report.手部嗜中性皮病:一例报告。
Acta Dermatovenerol Croat. 2023 Dec;31(3):148-50.
4
Glucocorticoid sparing effect on adalimumab for refractory pyoderma gangrenosum in patients with rheumatoid arthritis: A case series.糖皮质激素对类风湿关节炎患者难治性坏疽性脓皮病的阿达木单抗节约效应:病例系列
Mod Rheumatol Case Rep. 2025 Jul 25;9(2):1-5. doi: 10.1093/mrcr/rxae075.
5
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病:英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.
6
Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review.炎症性关节炎相关坏疽性脓皮病:系统评价。
Clin Rheumatol. 2021 Oct;40(10):3963-3969. doi: 10.1007/s10067-021-05768-7. Epub 2021 May 18.
7
Pyoderma Gangrenosum: A Presenting Feature of Rheumatoid Arthritis.坏疽性脓皮病:类风湿关节炎的一种表现特征。
Cureus. 2024 Jul 10;16(7):e64288. doi: 10.7759/cureus.64288. eCollection 2024 Jul.
8
Pyoderma gangrenosum of the breast treated with intravenous immunoglobulin.静脉注射免疫球蛋白治疗乳腺坏疽性脓皮病。
J Dermatol Case Rep. 2013 Jun 30;7(2):64-8. doi: 10.3315/jdcr.2013.1140.
9
PAPA Syndrome: Challenges in Achieving Long-Term Remission.PAPA 综合征:实现长期缓解的挑战。
Acta Dermatovenerol Croat. 2023 Nov;31(2):106-109.
10
Treatment of systemic sclerosis complicated with pyoderma gangrenosum with adalimumab: A case report of a rare disease.阿达木单抗治疗系统性硬化症合并坏疽性脓皮病 1 例:罕见病例报告。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241300137. doi: 10.1177/03946320241300137.

本文引用的文献

1
Pyoderma Gangrenosum: The Impact of Treatment Non-adherence on Disease Progression.坏疽性脓皮病:治疗依从性对疾病进展的影响。
Cureus. 2024 Jan 1;16(1):e51490. doi: 10.7759/cureus.51490. eCollection 2024 Jan.
2
Pyoderma gangrenosum after surgery for forefoot deformity in a patient with rheumatoid arthritis: A case report.类风湿关节炎患者前足畸形术后坏疽性脓皮病:病例报告。
Mod Rheumatol Case Rep. 2023 Dec 29;8(1):11-15. doi: 10.1093/mrcr/rxad051.
3
Pyoderma Gangrenosum: Treatment Options.坏疽性脓皮病:治疗选择。
Drugs. 2023 Sep;83(14):1255-1267. doi: 10.1007/s40265-023-01931-3. Epub 2023 Aug 23.
4
Successful switching treatment of adalimumab for refractory pyoderma gangrenosum in a patient with rheumatoid arthritis with prior use of tumour necrosis factor inhibitors: A case report and review of the literature.成功切换阿达木单抗治疗类风湿关节炎合并难治性坏疽性脓皮病患者:病例报告及文献复习。
Mod Rheumatol Case Rep. 2023 Jan 3;7(1):9-13. doi: 10.1093/mrcr/rxac023.
5
Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Final analysis of a 52-week phase 3 open-label study.阿达木单抗治疗日本脓疱性坏疽性脓皮病活动期溃疡患者:一项 52 周开放标签 3 期研究的最终分析。
J Dermatol. 2022 May;49(5):479-487. doi: 10.1111/1346-8138.16337. Epub 2022 Mar 3.
6
Successful treatment of ulcerated pyoderma gangrenosum with baricitinib, a novel JAK inhibitor.新型JAK抑制剂巴瑞替尼成功治疗溃疡性坏疽性脓皮病
J Transl Autoimmun. 2021 Apr 15;4:100099. doi: 10.1016/j.jtauto.2021.100099. eCollection 2021.
7
Rheumatoid arthritis and pyoderma gangrenosum: a population-based case-control study.类风湿性关节炎与坏疽性脓皮病:一项基于人群的病例对照研究。
Clin Rheumatol. 2021 Feb;40(2):521-528. doi: 10.1007/s10067-020-05253-7. Epub 2020 Jul 1.
8
Prevalence estimates for pyoderma gangrenosum in the United States: An age- and sex-adjusted population analysis.美国坏疽性脓皮病的流行率估计:年龄和性别调整后的人群分析。
J Am Acad Dermatol. 2020 Aug;83(2):425-429. doi: 10.1016/j.jaad.2019.08.001. Epub 2019 Aug 7.
9
Pyoderma gangrenosum - a guide to diagnosis and management .坏疽性脓皮病—诊断与治疗指南
Clin Med (Lond). 2019 May;19(3):224-228. doi: 10.7861/clinmedicine.19-3-224.
10
Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders.风湿性疾病患者对生物制剂的反常皮肤反应。
Front Pharmacol. 2019 Mar 26;10:282. doi: 10.3389/fphar.2019.00282. eCollection 2019.